SUN Pharmaceutical Industries Limited — Rosuvastatin Exporter Profile
Indian Pharmaceutical Exporter · #5 for Rosuvastatin · $30.9M export value · DGFT Verified
SUN Pharmaceutical Industries Limited is the #5 Indian exporter of Rosuvastatin with $30.9M in export value and 619 verified shipments. SUN Pharmaceutical Industries Limited holds a 6.7% market share in Rosuvastatin exports across 20 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.
SUN Pharmaceutical Industries Limited — Rosuvastatin Export Profile: Buyers & Destinations
Where Does SUN Pharmaceutical Industries Limited Export Rosuvastatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BELGIUM | $10.3M | 353 | 56.8% |
| SRI LANKA | $1.6M | 41 | 9.0% |
| MYANMAR | $1.3M | 32 | 7.1% |
| CANADA | $1.1M | 32 | 5.8% |
| SOUTH AFRICA | $1.0M | 27 | 5.6% |
| BRAZIL | $861.1K | 52 | 4.7% |
| AUSTRALIA | $589.3K | 24 | 3.2% |
| OMAN | $282.9K | 12 | 1.6% |
| MAURITIUS | $255.5K | 12 | 1.4% |
| UNITED ARAB EMIRATES | $200.0K | 4 | 1.1% |
SUN Pharmaceutical Industries Limited exports Rosuvastatin to 20 countries. The largest destination is BELGIUM accounting for 56.8% of SUN Pharmaceutical Industries Limited's Rosuvastatin shipments, followed by SRI LANKA (9.0%) and MYANMAR (7.1%). These destinations reflect SUN Pharmaceutical Industries Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Rosuvastatin from SUN Pharmaceutical Industries Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $10.0M | 341 |
| MYIT MAHAR TRADING CO., LTD. | MYANMAR | $524.5K | 13 |
| RANBAXY PHARMACEUTICALS PTY LTD | SOUTH AFRICA | $455.0K | 11 |
| SUN PHARMA CANADA INC | CANADA | $408.4K | 12 |
| RANBAXY PHARMACEUTICALS PTY LTD., | SOUTH AFRICA | $380.9K | 10 |
| MYIT MAHAR TRADING CO. LIMITED | MYANMAR | $372.9K | 8 |
| M/S. RANBAXY FARMACEUTICA LTDA : | BRAZIL | $363.7K | 17 |
| THE HONGKONG AND SHANGHAI BANKING C | SRI LANKA | $331.8K | 8 |
| TO THE ORDER | SRI LANKA | $319.3K | 8 |
| NOTIFY: | SRI LANKA | $254.9K | 6 |
SUN Pharmaceutical Industries Limited supplies Rosuvastatin to 79 buyers globally. The largest buyer is YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), followed by MYIT MAHAR TRADING CO., LTD. (MYANMAR) and RANBAXY PHARMACEUTICALS PTY LTD (SOUTH AFRICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Rosuvastatin Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?
India exported $321.1M worth of Rosuvastatin through 13,477 shipments from 427 suppliers to 143 countries, serving 1,314 buyers globally. SUN Pharmaceutical Industries Limited contributes $30.9M to this total, accounting for 6.7% of India's Rosuvastatin exports. SUN Pharmaceutical Industries Limited ships Rosuvastatin to 20 countries through 79 buyers.
What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Rosuvastatin Exports?
SUN Pharmaceutical Industries Limited's average Rosuvastatin shipment value is $50.0K per consignment, based on 619 shipments totaling $30.9M. The largest destination is BELGIUM (56.8% of SUN Pharmaceutical Industries Limited's Rosuvastatin exports).
How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Rosuvastatin Exporters?
SUN Pharmaceutical Industries Limited ranks #5 among 427 Indian Rosuvastatin exporters with a 6.7% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($58.9M), GLENMARK PHARMACEUTICALS LIMITED ($44.3M), BIOCON PHARMA LIMITED ($32.6M). SUN Pharmaceutical Industries Limited processed 619 shipments to 20 destination countries.
What Rosuvastatin Formulations Does SUN Pharmaceutical Industries Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ROSUVASTATIN CALCIUM TABLETS 10MG ( ROSU | $688.2K | 20 |
| ROSUVASTATIN CALCIUM TABLETS 10MG ( ROSUVASTATINE SUN 10MG FC TAB ) EACH FILM-COATED TABLET CONTAINS: ROSUVASTATIN CALCI | $473.7K | 14 |
| ROSUVASTATIN CALCIUM TABLETS 5MG ( ROSUV | $402.0K | 14 |
| ROSUVASTATIN CALCIUM TABLETS 20MG ( ROSU | $357.9K | 11 |
| ROSUVASTATIN CALCIUM TABLETS 20MG ( RIDL | $281.9K | 8 |
| ROSVATOR TAB 10mg (ROSUVASTATIN CALCIUM | $238.8K | 5 |
| ROSUVAS TAB 10 MG EACH TABLET CONTAINS ROSUVASTATIN CALCIUM EQUIVALENT TO ROSUVASTATIN 10 MG SAP CODE : 1079012***NOS | $235.2K | 6 |
| ROZAVEL TAB 10MG EACH FILM COATED TABLETCONT:ROSUVASTATIN CALCIUM EQ. TO ROSUVASTATIN PH.EUR 10MG SAP CODE : 1146937***NOS | $198.8K | 4 |
| ROSUVASTATIN CALCIUM TABLETS 20MG ( ROSUVASTATINE SUN 20MG FC TAB ) EACH FILM-COATED TABLET CONTAINS: ROSUVASTATIN CALCI | $188.3K | 5 |
| ROSUVASTATIN CALCIUM TABLETS 10MG ( RIDL | $184.1K | 7 |
SUN Pharmaceutical Industries Limited exports 401 distinct Rosuvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ROSUVASTATIN CALCIUM TABLETS 10MG ( ROSU with 20 shipments worth $688.2K.
How Does SUN Pharmaceutical Industries Limited Compare to Nearest Rosuvastatin Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | BIOCON PHARMA LIMITED | $32.6M | 652 | 9 | $50.0K |
| 6 | AUROBINDO PHARMA LTD | $31.1M | 697 | 6 | $44.6K |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LIMITED ★ | $30.9M | 619 | 20 | $50.0K |
| 7 | TORRENT PHARMACEUTICALS LTD | $21.1M | 512 | 13 | $41.2K |
| 1 | STRIDES PHARMA SCIENCE LIMITED | $21.0M | 420 | 3 | $50.0K |
SUN Pharmaceutical Industries Limited ranks #5 among 427 Indian Rosuvastatin exporters. Average shipment value of $50.0K compared to the market average of $751.9K. The closest competitors by value are BIOCON PHARMA LIMITED and AUROBINDO PHARMA LTD.
Which Indian Ports Ship Rosuvastatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 1,090 | 8.1% |
| SAHAR AIR | 921 | 6.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 909 | 6.7% |
| HYDERABAD ICD (INSNF6) | 878 | 6.5% |
| DELHI AIR CARGO ACC (INDEL4) | 769 | 5.7% |
| JNPT/ NHAVA SHEVA SEA | 699 | 5.2% |
| DELHI AIR | 635 | 4.7% |
| HYDERABAD ICD | 550 | 4.1% |
What Other Cardiovascular Products Does SUN Pharmaceutical Industries Limited Export?
SUN Pharmaceutical Industries Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Rosuvastatin Exports
Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)
In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)
The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)
SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)
Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.
About SUN Pharmaceutical Industries Limited
SUN Pharmaceutical Industries Limited exports 118 products worth $979.8M. Beyond Rosuvastatin, top products include Strip, Esomeprazole, Magnesium, Calcium, Omeprazole. View the complete SUN Pharmaceutical Industries Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rosuvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rosuvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 647 individual customs records matching SUN Pharmaceutical Industries Limited exporting Rosuvastatin, covering 401 formulations to 20 countries via 79 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 143+ countries, 1,314+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rosuvastatin Export Data from SUN Pharmaceutical Industries Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for SUN Pharmaceutical Industries Limited's Rosuvastatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SUN Pharmaceutical Industries Limited
Full Company Profile →
118 products · $979.8M total trade · 25 categories
Rosuvastatin Stats
Company Overview
Top Products by SUN Pharmaceutical Industries Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for SUN Pharmaceutical Industries Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rosuvastatin. For current shipment-level data, contact TransData Nexus.